Abstract
Genomics is proposed to improve predictive toxicology and regulatory decision making. The Government of Canada established the Genomics RD 2) national and international collaboration is essential to building capacity and leveraging resources; 3) collaborative case studies, exchange programs, international validation exercises and Health Canada's Genomics Working Group as key exercises to overcome existing challenges to the application of genomics. These opinions provide a basis for selecting projects funding areas to maximise genomics impacts on regulatory decision making.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have